ERICA GOLDMAN: Open Payments
NPI 1427412642 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 20 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $301 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 6 | $131 |
| Merck Sharp & Dohme LLC | 1 | $106 |
| E.R. Squibb & Sons, L.L.C. | 2 | $53 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| GENZYME CORPORATION | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| BeiGene USA, Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: Onivyde, WELIREG, OPDIVO, ERLEADA, AYVAKIT, ORGOVYX, Nubeqa, CABOMETYX.
Industry payments across MI — which companies pay providers there.
